Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for weight recidivism after sleeve gastrectomy

By sjmartinez • February 6, 2025

Bahdi F, Shah S, Dahoud F, Farooq M, Kozan P, Kim S, Sedarat A, Shen N, Thaker A, Kolb JM, Dutson E, Muthusamy VR, Issa D. Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for weight recidivism after sleeve gastrectomy. Clin Obes. 2025 Feb 5:e70001. doi: 10.1111/cob.70001. Epub ahead of print. PMID: 39909715.

Tags: Digestive Diseases, Endocrinology, endoscopic sleeve gastroplasty, Fellow, Publications, semaglutide, Sleeve gastrectomy, tirzepatide, Veterans Administration

MicroRNA Sequencing of Serum Exosomes Reveals miR205-5p as an Anti-Fibrogenic Factor Against Intestinal Fibrosis in Crohn’s Disease

Xie Y, van Daelen M, Park R, Almaraz I, Fontenot L, Rieder F, Ho W, Limketkai B, Shih DQ, Wei M, Li Y, Koon HW.[...]

De novo DUOX2 expression in neutrophil subsets shapes the pathogenesis of intestinal disease

Singh AK, Ainciburu M, Wynne K, Bhat SA, Blanco A, Tzani I, Akiba Y, Lalor SJ, Kaunitz J, Bourke B, Kelly VP, Doherty GA, Zerbe[...]

Vitamin C reduces gastric pH in pharmacologically induced hypochlorhydria: a potential approach for mitigating pH-dependent drug-drug interactions of weak-base drugs

Fadda HM, Shin A, Waseem MR, Camilleri M. Vitamin C reduces gastric pH in pharmacologically induced hypochlorhydria: a potential approach for mitigating pH-dependent drug-drug interactions[...]